EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 272 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,069,000 | +62.7% | 21,341 | +69.7% | 0.01% | +25.0% |
Q3 2019 | $657,000 | -71.3% | 12,573 | -73.5% | 0.00% | -71.4% |
Q2 2019 | $2,290,000 | +383.1% | 47,415 | +404.4% | 0.01% | +600.0% |
Q1 2019 | $474,000 | +500.0% | 9,400 | +601.0% | 0.00% | +100.0% |
Q4 2018 | $79,000 | -98.6% | 1,341 | -98.9% | 0.00% | -96.7% |
Q4 2017 | $5,451,000 | – | 117,293 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Zebra Capital Management LLC | 25,250 | $784,000 | 2.30% |
Global Alpha Capital Management Ltd. | 418,030 | $12,976,000 | 1.40% |
AIMZ Investment Advisors, LLC | 70,588 | $2,191,000 | 1.05% |
PALISADE CAPITAL MANAGEMENT, LP | 566,080 | $17,571,000 | 0.48% |
RICE HALL JAMES & ASSOCIATES, LLC | 261,533 | $8,118,000 | 0.39% |
EARNEST PARTNERS LLC | 1,844,621 | $57,257,000 | 0.38% |
SummerHaven Investment Management, LLC | 14,476 | $449,000 | 0.30% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 1,085,874 | $33,706,000 | 0.26% |
Ridgewood Investments LLC | 10,004 | $311,000 | 0.24% |
DUALITY ADVISERS, LP | 65,650 | $2,038,000 | 0.20% |